Provost Miriam
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Provost Miriam. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| TMDX | VP, Global Regulatory Affairs | Sale | 1,509 | $75.10 | $113,326 | Dec 13, 2023 |
| TMDX | VP, Global Regulatory Affairs | Option Exercise | 1,785 | $3.22 | $5,748 | Aug 31, 2023 |
| TMDX | VP, Global Regulatory Affairs | Award / Grant | 5,685 | — | — | Feb 20, 2023 |
| TMDX | VP, Global Regulatory Affairs | Sale | 1,620 | $63.00 | $102,060 | Dec 13, 2022 |
| TMDX | VP, Global Regulatory Affairs | Option Exercise | 1,149 | $16.14 | $18,545 | Dec 9, 2022 |
| TMDX | VP of US Regulatory & FDA Rel. | Option Exercise | 884 | $3.22 | $2,846 | Dec 23, 2021 |
| TMDX | VP of US Regulatory & FDA Rel. | Sale | 3,877 | $31.34 | $121,505 | Sep 15, 2021 |
| TMDX | VP of US Regulatory & FDA Rel. | Option Exercise | 2,206 | $3.22 | $7,103 | Jul 30, 2021 |
| TMDX | VP of US Regulatory & FDA Rel. | Option Exercise | 4,600 | $3.22 | $14,812 | Dec 11, 2020 |